/Investor DB

RUSNANO

Government fund

Moscow · Seed–Series A

Find your way into RUSNANO

Sign up to see every warm intro you have to RUSNANO

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RUSNANO team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

RUSNANO Group is a Russian state-backed group centered on nanotechnology and industrial innovation. It emphasizes moving scientific developments from patents to production, with key focus areas described as energy logistics, natural resource management, and sustainability and infrastructure. The group is recruiting experts in pulsed-plasma and resonance technologies, biotechnology, and materials morphology, and promotes an integrated technology platform (MARS) addressing industrial waste. The page is primarily a corporate overview, news feed, and careers listing rather than a detailed investment thesis.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Moscow, RU
Instruments
Debt · Equity
Founded
2007
Tracked investments
5
IPOs
1

What they invest in

from 4 of 5 portfolio companies

Biotech ×2Cleantech ×2AI & Machine Learning ×1Deep Tech ×1Energy ×1Healthtech ×1SaaS ×1

HQs:United States×4

Investments · 5 tracked

founders shown can be your intro path
Cartesian Therapeutics (NASDAQ: RNAC)cartesiantherapeutics.comin𝕏NASDAQ: RNAC

Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies aimed at treating autoimmune diseases.

BiotechHealthtechWatertown, US

Metin Kurtoglu(Executive Officer)Omid Farokhzad(Director)Chris Jewell(Executive Officer)inCarsten Brunn(President, CEO & Chairman of the Board)inEmily English(Executive Officer)inBlaine Davis(Executive Officer)in

Co-investorsK2 HealthVenturesMaryland TEDCOSchooner CapitalTEDCO+ND CapitalPolaris Partners

Quantenna Communicationsquantenna.comin

Next-generation low-power wireless semiconductors focused on Wi-Fi networks.

Fremont, US

Sam Heidari(Founder)inAndrea Goldsmith(Founder)Behrooz Rezvani(Founder)

BoardMichael Goguen(Director)Edwin B Hooper III(Director)Dmitry Akhanov(Director)

Co-investorsCelesta CapitalCenterview Capital TechnologyDag VenturesGrazia Equity GmbHSequoia CapitalVenrock+2 more

TaKaDutakadu.comin𝕏

TaKaDu provides a cloud-based SaaS analytics service, known as Central Event Management (CEM), that detects, analyzes and manages water network events such as leaks, bursts, faulty assets and data issues to reduce non-revenue water loss.

AI & Machine LearningCleantechSaaS

Amir Peleg(Founder)in

Co-investorsCrescendo Venture PartnersEmerald Technology Ventures AgABB Technology Ventures

Tri Alpha Energytae.comin𝕏

TAE Technologies develops hydrogen-boron (aneutronic) fusion power using a beam-driven Field-Reversed Configuration reactor design, aiming to deliver utility-scale fusion electricity to the grid in the early 2030s.

CleantechDeep TechEnergyFoothill Ranch, US

Norman Rostoker(Founder)Michl Binderbauer(Founder)inCedric Burgher(Chief Financial Officer)in

Co-investorsNew Enterprise Associates (NEA)Chevron Technology VenturesWellcome TrustCapital FactoryUpVentures CapitalVenrock+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Panacela Labs

Exits · 1

1 IPOs

Cartesian Therapeutics (NASDAQ: RNAC)NASDAQ: RNAC

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Cartesian Therapeutics (NASDAQ: RNAC)—$14.00Jun 2016$19.3M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has RUSNANO made?
RUSNANO has 5 tracked investments, 1 of which have exited.
What stage does RUSNANO invest at?
RUSNANO invests at the Seed, Series A stages.
What sectors does RUSNANO focus on?
RUSNANO focuses on Advanced Manufacturing, Biotech, Deep Tech, Energy, New Materials, Semiconductors.
Where is RUSNANO located?
RUSNANO is headquartered in Moscow, RU.

Similar investors

Featured in lists